Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2025-12-25 @ 1:27 AM
NCT ID:
NCT05070494
Eligibility Criteria:
Inclusion Criteria:
* Age ≥18 years
* Received kidney replacement therapy with dialysis for more than 1 month.
* Hemodialysis at least 3 times a week
* (Kt/v) greater than 1.2
* Never received an organ transplant.
* Life expectancy of more than 1 year
* Research participants or representatives are welcome to join the project by signing.
Exclusion Criteria:
* History of any vaccinations in the 4 weeks prior to the study.
* History of receiving influenza vaccine 6 months before entering this study.
* History of allergy to flu vaccine or allergic to egg white
* Fever or headache, muscle pain (influenza-like illness) 3 days before vaccination
* Thrombocytopenia
* On immunosuppressive drug (Prednisolone 15 mg daily or equivalent for two weeks in a row in the previous 3 months) or immunocompromised patient
* Patient or family history of having had Guillain-Barre disease. (Guillain-Barre syndrome)
* The research participant or his representative refuses or requests to withdraw.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05070494
Study Brief:
Protocol Section:
NCT05070494